UK Government Announces Funding for Second Sight’s Argus II “Bionic Eye”

SYLMAR, Calif. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (Nasdaq:EYES) (“Second Sight”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients suffering from Retinitis Pigmentosa (RP), today announced, following a positive recommendation from advisors to the UK Government’s healthcare funding authority for specialized services in England that, for the first time in the UK, the publicly-funded